- Home
- APLT vs CXDO Comparison
APLT vs CXDO Comparison
Compare APLT & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- CXDO
- Stock Information
- Founded
- APLT 2016
- CXDO 1995
- Country
- APLT United States
- CXDO United States
- Employees
- APLT N/A
- CXDO N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- CXDO Telecommunications Equipment
- Sector
- APLT Health Care
- CXDO Telecommunications
- Exchange
- APLT Nasdaq
- CXDO Nasdaq
- Market Cap
- APLT 140.8M
- CXDO 139.6M
- IPO Year
- APLT 2019
- CXDO 1998
- Fundamental
- Price
- APLT $1.10
- CXDO $5.30
- Analyst Decision
- APLT Buy
- CXDO Strong Buy
- Analyst Count
- APLT 6
- CXDO 2
- Target Price
- APLT $6.60
- CXDO $6.50
- AVG Volume (30 Days)
- APLT 10.8M
- CXDO 176.5K
- Earning Date
- APLT 11-07-2024
- CXDO 11-06-2024
- Dividend Yield
- APLT N/A
- CXDO N/A
- EPS Growth
- APLT N/A
- CXDO N/A
- EPS
- APLT N/A
- CXDO 0.05
- Revenue
- APLT N/A
- CXDO $58,762,000.00
- Revenue This Year
- APLT N/A
- CXDO $15.52
- Revenue Next Year
- APLT $5,117.00
- CXDO $10.52
- P/E Ratio
- APLT N/A
- CXDO $113.79
- Revenue Growth
- APLT N/A
- CXDO 16.41
- 52 Week Low
- APLT $1.03
- CXDO $2.92
- 52 Week High
- APLT $10.62
- CXDO $7.59
- Technical
- Relative Strength Index (RSI)
- APLT 17.64
- CXDO 52.44
- Support Level
- APLT $1.03
- CXDO $4.90
- Resistance Level
- APLT $1.37
- CXDO $5.27
- Average True Range (ATR)
- APLT 0.33
- CXDO 0.23
- MACD
- APLT -0.15
- CXDO 0.00
- Stochastic Oscillator
- APLT 0.75
- CXDO 57.14
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of revenue from the Cloud telecommunications segment.